Teladoc Health Logo
US87918A1051
A14VPK
TDOC

Teladoc Health

Chargement des cours...

Prévisions

L'objectif de cours moyen des analystes est de 8,44 € (+6,03 %). La médiane est de 8,17 € (+2,64 %).

Acheter
  15
Conserver
  27
Vendre
  0

Discussions dans la communauté

Il n'y a pas encore de discussion sur cet actif.

Lancer une discussion

  • BetterHelp and Sophia Bush launch The Permission Project to address women's mental health

    BetterHelp launched The Permission Project, a therapist-developed initiative partnered with Sophia Bush that provides a Rewrite Guide, 10,000 hours of free therapy and a $100,000 investment in therapists focused on women’s mental health. The program is based on research identifying social tensions—like being ambitious but likeable—that correlate with rising anxiety and depression among women and offers actionable steps to counter them. Bush, who contributed to the project, emphasizes systemic causes of women's unrecognized labor and the need for cultural change alongside individual support. » Plus sur forbes.com


  • Teladoc Health appoints Michael Grasher as chief financial officer

    Teladoc Health has appointed Michael Grasher as CFO, effective immediately. Grasher has more than 30 years of experience in the insurance and financial services sector, including over 12 years in CFO roles at companies such as IFG Companies, Fortegra and AMERISAFE, and he also spent many years in equity research. » Plus sur de.investing.com


  • Teladoc Health appoints Mark V. Anquillare to the board of directors

    Teladoc Health has appointed Mark V. Anquillare, former president and COO of Verisk Analytics, to its board of directors. He will serve on the audit and compensation committees and brings more than 30 years of experience in finance and leadership roles, including overseeing Verisk’s 2009 IPO. Anquillare also sits on several other boards; Teladoc Health provides virtual healthcare services through partnerships with insurers, employers and health systems. » Plus sur de.investing.com


  • Teladoc reports revenue decline and cuts annual forecast – stock falls sharply

    Teladoc reported Q2 revenue of $606.9 million, missing the analyst consensus of about $615 million, while adjusted EPS of -$0.21 beat expectations. Consumer segment BetterHelp shrank 12% to $212.6 million. For Q3 management expects revenue of $569–609 million and lowered the full-year guidance to $2.36–2.45 billion (previously $2.48–2.58 billion), which weighed heavily on the stock in premarket trading. CEO Chuck Divita cited provider capacity constraints as the reason for weaker revenue realization; over the past six months there have been only insider sales. » Plus sur de.investing.com


  • Teladoc plunges about 24% after Q2 results and weak outlook

    Teladoc reported a Q2 EPS loss of -$0.21 with revenue of $606.9 million, missing consensus. The Q3 outlook of $569–609 million is well below the $629 million consensus, and the full-year loss forecast was lowered to -$1.00 to -$0.75. The combination of a revenue miss, reduced guidance and continued drag from the BetterHelp segment triggered the sharp share decline. Investors are now awaiting management comments on the conference call for signs of a return to revenue growth. » Plus sur de.investing.com

En 2022, Teladoc Health a déjà versé 0,26 € de dividendes. Le dernier versement a eu lieu en mars 2022.

Données financières de l'entreprise

Au dernier trimestre, Teladoc Health a réalisé un chiffre d'affaires de 534,21 M € et un bénéfice net de -23,78 M €
(EUR) septembre 2026
YoY
Chiffre d'affaires 534,21 M 0,08 %
Bénéfice brut 366,25 M 2,15 %
Bénéfice net -23,78 M 43,63 %
EBITDA 61,03 M 54,17 %

Données fondamentales

Indicateur Valeur
Capitalisation boursière
1,46 Md €
Nombre d'actions
182,29 M
Plus haut/bas sur 52 semaines
8,98 € - 3,99 €
Dividendes Non
Bêta
1,97
Ratio P/E
-10,25
Ratio PEG
-0,25
Ratio P/B
1,24
Ratio P/S
0,65

Profil de l'entreprise

Teladoc Health, Inc. fournit des services de soins de santé virtuels aux États-Unis et à l'international. La société propose un portefeuille de services et de solutions couvrant les affections médicales non urgentes, ponctuelles, chroniques et complexes, notamment le diabète, l'hypertension, la maladie rénale chronique, le cancer, l'insuffisance cardiaque congestive et les troubles de santé mentale. Elle offre une gamme de programmes et de services, comprenant des solutions de télésanté en médecine générale et en médecine spécialisée, la gestion des maladies chroniques, des services médicaux experts, des solutions de santé mentale, ainsi que des services de plateforme et de programmes. La société s'adresse aux employeurs, aux régimes de santé, aux hôpitaux et systèmes hospitaliers, ainsi qu'aux compagnies d'assurance et de services financiers, de même qu'aux membres individuels. Elle commercialise ses produits et services sous les marques Teladoc, Livongo et BetterHelp. La société était auparavant connue sous le nom de Teladoc, Inc. et a changé sa dénomination en Teladoc Health, Inc. en août 2018. La société a été constituée en 2002 et son siège social se situe à Purchase, dans l'État de New York.

Nom
Teladoc Health
PDG
Charles Divita
Siège social New York, ny
États-Unis
Site web
Secteur
Santé
Industrie
Prestataires et services de santé
Introduction en bourse
30/06/2015
Employés 5 124

Symboles boursiers

Bourse Symbole
NYSE
TDOC
London Stock Exchange
0LDR.L
XETRA
4LL.F
Frankfurt
4LL.F
Düsseldorf
4LL.DU
London
0LDR.L
SIX
4LL.SW
München
4LL.MU
🍪

Parqet  utilise des cookies. En savoir plus